JAMA Author Interviews

Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020. Related Article: Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine

Interview with Aaron S. Kesselheim, MD, author of Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency Related Article(s): Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency

Interview with Atul J Butte, MD, PhD, author of The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies Related Article: The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies

New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020. Related Article(s): Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018

Interview with Deborah Korenstein, MD, and Daniel J. Morgan, MD, author of Improving Physician Communication About Treatment Decisions: Reconsideration of “Risks vs Benefits” Related Article(s): Improving Physician Communication About Treatment Decisions

A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020. Related Article(s): Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19

Interview with Catherine Lucey, MD, FACP, author of The Transformational Effects of COVID-19 on Medical Education

Paul A. Offit, MD, of the Children's Hospital of Philadelphia provides an update on COVID-19 vaccine development. Recorded August 24, 2020. Related Article: Developing a SARS-CoV-2 Vaccine at Warp Speed

CDC Director Robert Redfield, MD, discusses recent developments in the COVID-19 pandemic and US response, including prospects for dual outbreaks of COVID-19 and influenza in the fall and winter. Related Article(s): Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic

Ezekiel Emanuel, MD, PhD, of the University of Pennsylvania's Perelman School of Medicine, Department of Medical Ethics and Health Policy, discusses recent developments in the COVID-19 pandemic. Recorded August 19, 2020. Related Article(s): The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)